|
(2Z)-2-[1-[5-(1H-pyrrol-2-yl)-2-furyl]ethylidene]pyrrole |
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Manger M, et al. 2005. Chembiochem |
|
(2Z)-5-[5-[(2Z)-hexa-2,5-dien-2-yl]-1H-pyrrol-2-yl]-2-[(5-hex-5-enyl-1H-pyrrol-2-yl)methylidene]-3-methoxypyrrole |
Depiction based on curated SMILES
H
3
C
O
H
2
C
N
H
CH
3
N
N
H
H
2
C
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Manger M, et al. 2005. Chembiochem |
|
2-Chloro-4beta-(4-chlorophenyl)-3,4,6,7,12,12balpha-hexahydro-12-(2-fluorobenzoyl)indolo[2,3-a]quinolizine-6alpha-carboxylic acid |
Depiction based on curated SMILES
N
O
HO
F
Cl
H
H
Cl
N
H
O
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Nören-Müller A, et al. 2006. Proc Natl Acad Sci U S A |
|
(4S,6S,12bR)-4-(4-bromophenyl)-2-chloro-12-(2,3-difluorobenzoyl)-3,4,6,7,12,12b-hexahydroindolo[2,3-a]quinolizine-6-carboxylic acid |
Depiction based on curated SMILES
O
F
F
O
HO
Br
H
H
N
H
Cl
N
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Nören-Müller A, et al. 2006. Proc Natl Acad Sci U S A |
|
(4S)-2-Chloro-4beta-(4-bromophenyl)-12-[[2-(methylthio)-3-pyridyl]carbonyl]-3,4,6,7,12,12balpha-hexahydroindolo[2,3-a]quinolizine-6alpha-carboxylic acid |
Depiction based on curated SMILES
N
N
O
S
CH
3
Cl
H
H
Br
N
O
HO
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Nören-Müller A, et al. 2006. Proc Natl Acad Sci U S A |
|
1-(4-chlorobenzoyl)-3-decyl-2-methylindole-5-sulfonic acid |
Depiction based on curated SMILES
S
O
O
OH
O
Cl
H
3
C
H
3
C
N
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Nören-Müller A, et al. 2006. Proc Natl Acad Sci U S A |
|
2-(1-methylhydrazinyl)-4,6-di(piperidin-1-yl)-1,3,5-triazine |
Depiction based on curated SMILES
H
2
N
N
CH
3
N
N
N
N
N
|
Mycobacterium |
Motility |
Preclinical (in vitro) |
Ouertatani-Sakouhi H, et al. 2017. PLoS One |
|
2-(2,5-dimethyl-1H-pyrrol-1-yl)-5-hydroxybenzoic acid |
Depiction based on curated SMILES
H
3
C
OH
O
HO
H
3
C
N
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Manger M, et al. 2005. Chembiochem |
|
C82 |
Depiction based on curated SMILES
N
H
S
O
CH
3
O
H
3
C
O
N
N
|
Mycobacterium |
Immune modulation |
Preclinical (in vitro) |
Karanja CW, et al. 2021. ACS Infect Dis |
|
2-benzoyl-5-(4-phenylbenzoyl)-3,4-dihydro-1H-pyrido[4,3-b]indole-8-sulfonic acid |
Depiction based on curated SMILES
O
N
N
S
O
O
OH
O
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Nören-Müller A, et al. 2006. Proc Natl Acad Sci U S A |
|
| | |